Esperion (ESPR) CFO sells shares to cover taxes on vested RSUs

robot
Abstract generation in progress

Esperion Therapeutics CFO Benjamin Halladay sold 6,424 shares of the company’s common stock at $2.705 per share to cover tax obligations on vested restricted stock units. This transaction, reported in an SEC Form 4 filing, leaves him with 713,602 direct shares. The sale is categorized as tax-related and not a discretionary reduction of his equity stake in Esperion.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin